UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Extraction of β‐galactosidase from Saccharomyces fragilis IZ 275 grown in cheese whey

Journal of chemical technology and biotechnology (1986), 2022-12, Vol.97 (12), p.3481-3488

2022

Volltextzugriff (PDF)

Comparison of bioethanol and beta‐galactosidase production by Kluyveromyces and Saccharomyces strains grown in cheese whey

International journal of dairy technology, 2019-08, Vol.72 (3), p.409-415

2019

Volltextzugriff (PDF)

What do patents tell us about microalgae in agriculture?

AMB Express, 2021-11, Vol.11 (1), p.154-154, Article 154

2021

Volltextzugriff (PDF)

Optimization of biomass production of Chlorella vulgaris grown in desalination concentrate

Journal of applied phycology, 2015-08, Vol.27 (4), p.1473-1483

2015

Volltextzugriff (PDF)

Cell permeabilization of Kluyveromyces and Saccharomyces species to obtain potential biocatalysts for lactose hydrolysis

Acta scientiarum. Biological sciences, 2022-05, Vol.44 (1), p.e60336

2022

Volltextzugriff (PDF)

Reducción de proteínas y glucosa por reacción de Maillard en leche con lactosa hidrolisada

Revista chilena de nutrición, 2020-02, Vol.47 (1), p.14-21

2020

Volltextzugriff (PDF)

Determination of Cell Permeabilization and Beta-Galactosidase Extraction from Aspergillus oryzae CCT 0977 Grown in Cheese Whey

International Journal of Chemical Engineering, 2018-01, Vol.2018 (2018), p.1-6

2018

Volltextzugriff (PDF)

Teores de proteínas e lipídeos de Chlorella sp. cultivada em concentrado de dessalinização residual

Ciência rural, 2015-02, Vol.45 (2), p.364-370

2015

Volltextzugriff (PDF)

Permeabilization of Saccharomyces fragilis IZ 275 cells with ethanol to obtain a biocatalyst with lactose hydrolysis capacity

Acta scientiarum. Biological sciences, 2016, Vol.38 (2), p.149

2016

Volltextzugriff (PDF)

Substrate consumption and beta-galactosidase production by Saccharomyces fragilis IZ 275 grown in cheese whey as a function of cell growth rate

Biocatalysis and agricultural biotechnology, 2019-09, Vol.21, p.101335, Article 101335

2019

Volltextzugriff (PDF)

Growing ＂Chlorella Vulgaris＂ in Photobioreactor by Continuous Process Using Concentrated Desalination: Effect of Dilution Rate on Biochemical Composition

International Journal of Chemical Engineering, 2014-01, Vol.2014 (2014), p.127-132

2014

Volltextzugriff (PDF)

Lactose hydrolysis potential and thermal stability of commercial β-galactosidase in UHT and skimmed milk

Ciência e tecnologia de alimentos, 2016-01, Vol.36 (1), p.159-165

2016

Volltextzugriff (PDF)

Concentrated beta-galactosidase and cell permeabilization from Saccharomyces fragilis IZ 275 for beta-galactosidase activity in the hydrolysis of lactose

Ciência e tecnologia de alimentos, 2019-09, Vol.39 (3), p.524-530

2019

Volltextzugriff (PDF)

The Commands Trial: A Phase 3 Study of the Efficacy and Safety of Luspatercept Versus Epoetin Alfa for the Treatment of Anemia Due to IPSS-R Very Low-, Low-, or Intermediate-Risk MDS in Erythropoiesis Stimulating Agent-Naive Patients Who Require RBC Transfusions

Blood, 2020-11, Vol.136 (Supplement 1), p.1-2

2020

Volltextzugriff (PDF)

Neutrophil and platelet increases with luspatercept in lower-risk MDS: secondary endpoints from the MEDALIST trial

Blood, 2022-01, Vol.139 (4), p.624-629

2022

Volltextzugriff (PDF)

Longer-term benefit of luspatercept in transfusion-dependent lower-risk myelodysplastic syndromes with ring sideroblasts

Blood, 2022-11, Vol.140 (20), p.2170-2174

2022

Volltextzugriff (PDF)

BRUIN MCL-321: A phase 3, open-label, randomized study of pirtobrutinib versus investigator choice of BTK inhibitor in patients with previously treated, BTK inhibitor naïve mantle cell lymphoma

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.TPS7587-TPS7587

2023

Volltextzugriff (PDF)

Prospecção tecnológica de patentes sobre compostos bioativos de microalgas / Technological prospecting of patents on microalgae bioactive compounds

Brazilian Journal of Development, 2021-08, Vol.7 (8), p.81223-81236

2021

Volltextzugriff (PDF)

Atividade Antibacteriana de Extratos de Chlorella sorokiniana Obtidos por Extração com Diferentes Solventes Orgânicos

Ensaios e Ciência: Ciências Biológicas, Agrárias e da Saúde, 2024-07, Vol.28 (2), p.223-226

2024

Volltextzugriff (PDF)

Effect of Luspatercept on Biomarkers of Erythropoiesis in Patients (Pts) with Lower-Risk Myelodysplastic Syndromes (LR-MDS) in the Medalist Trial

Blood, 2020-11, Vol.136 (Supplement 1), p.38-39

2020

Volltextzugriff (PDF)

Produção de β- galactosidase Através da Saccharomyces fragilis Cultivada em Soro de Queijo

Ensaios e Ciência C Biológicas Agrárias e da Saúde, 2020-12, Vol.24 (4), p.337-342

2020

Volltextzugriff (PDF)

Luspatercept for myelodysplastic syndromes/myeloproliferative neoplasm with ring sideroblasts and thrombocytosis

Leukemia, 2022-05, Vol.36 (5), p.1432-1435

2022

Volltextzugriff (PDF)

BRUIN MCL-321: phase III study of pirtobrutinib versus investigator choice of BTK inhibitor in BTK inhibitor naive mantle cell lymphoma

Future oncology (London, England), 2022-11, Vol.18 (36), p.3961-3969

2022

Volltextzugriff (PDF)

Health-Related Quality of Life Outcomes in Patients with Myelodysplastic Syndromes with Ring Sideroblasts Treated with Luspatercept in the Medalist Study

Blood, 2020-11, Vol.136 (Supplement 1), p.10-12

2020

Volltextzugriff (PDF)

1 – 25 von 154

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(122)
Mit Volltextzugriff
(133)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(8)

Menü

Weitere Dienste

Einstellungen

Extraction of β‐galactosidase from Saccharomyces fragilis IZ 275 grown in cheese whey

Comparison of bioethanol and beta‐galactosidase production by Kluyveromyces and Saccharomyces strains grown in cheese whey

What do patents tell us about microalgae in agriculture?

Optimization of biomass production of Chlorella vulgaris grown in desalination concentrate

Cell permeabilization of Kluyveromyces and Saccharomyces species to obtain potential biocatalysts for lactose hydrolysis

Reducción de proteínas y glucosa por reacción de Maillard en leche con lactosa hidrolisada

Determination of Cell Permeabilization and Beta-Galactosidase Extraction from Aspergillus oryzae CCT 0977 Grown in Cheese Whey

Teores de proteínas e lipídeos de Chlorella sp. cultivada em concentrado de dessalinização residual

Permeabilization of Saccharomyces fragilis IZ 275 cells with ethanol to obtain a biocatalyst with lactose hydrolysis capacity

Substrate consumption and beta-galactosidase production by Saccharomyces fragilis IZ 275 grown in cheese whey as a function of cell growth rate

Growing ＂Chlorella Vulgaris＂ in Photobioreactor by Continuous Process Using Concentrated Desalination: Effect of Dilution Rate on Biochemical Composition

Lactose hydrolysis potential and thermal stability of commercial β-galactosidase in UHT and skimmed milk

Concentrated beta-galactosidase and cell permeabilization from Saccharomyces fragilis IZ 275 for beta-galactosidase activity in the hydrolysis of lactose

The Commands Trial: A Phase 3 Study of the Efficacy and Safety of Luspatercept Versus Epoetin Alfa for the Treatment of Anemia Due to IPSS-R Very Low-, Low-, or Intermediate-Risk MDS in Erythropoiesis Stimulating Agent-Naive Patients Who Require RBC Transfusions

Neutrophil and platelet increases with luspatercept in lower-risk MDS: secondary endpoints from the MEDALIST trial

Longer-term benefit of luspatercept in transfusion-dependent lower-risk myelodysplastic syndromes with ring sideroblasts

BRUIN MCL-321: A phase 3, open-label, randomized study of pirtobrutinib versus investigator choice of BTK inhibitor in patients with previously treated, BTK inhibitor naïve mantle cell lymphoma

Prospecção tecnológica de patentes sobre compostos bioativos de microalgas / Technological prospecting of patents on microalgae bioactive compounds

Atividade Antibacteriana de Extratos de Chlorella sorokiniana Obtidos por Extração com Diferentes Solventes Orgânicos

Effect of Luspatercept on Biomarkers of Erythropoiesis in Patients (Pts) with Lower-Risk Myelodysplastic Syndromes (LR-MDS) in the Medalist Trial

Produção de β- galactosidase Através da Saccharomyces fragilis Cultivada em Soro de Queijo

Luspatercept for myelodysplastic syndromes/myeloproliferative neoplasm with ring sideroblasts and thrombocytosis

BRUIN MCL-321: phase III study of pirtobrutinib versus investigator choice of BTK inhibitor in BTK inhibitor naive mantle cell lymphoma

Health-Related Quality of Life Outcomes in Patients with Myelodysplastic Syndromes with Ring Sideroblasts Treated with Luspatercept in the Medalist Study

Efficacy and Safety of Luspatercept Treatment in Patients with Myelodysplastic Syndrome/Myeloproliferative Neoplasm with Ring Sideroblasts and Thrombocytosis (MDS/MPN-RS-T): A Retrospective Analysis from the Medalist Study

Suchergebnisse filtern